SEC Form 4 · accession 0001000229-19-000006
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Scott Hill
Officer — VP and CFO
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Dec 31, 2018 | M | 3,000 | $0.00 | A | 14,723 | D | |
| Common Shares | Dec 31, 2018 | F | 1,181 | $59.66 | D | 13,542 | D | |
| Common Shares | holding | — | — | — | 59 | I | 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance SharesF1 | $0.00 | Dec 31, 2018 | M | 3,000 | D | — | — | Common Shares | 3,000 | 0 | D |
Explanation of responses
- F1These awards vested at the end of a three-year performance period that began on January 1, 2016 and ended on December 31, 2018 (the "Performance Period"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period.